Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 30, 2020 16:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
December 06, 2020 10:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting

SEATTLE, Dec. 06, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
November 23, 2020 08:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

Studies reinforce clonoSEQ as standard of care in minimal residual disease (MRD) across eight disease statesReal-world evidence shows treatment decisions based on precise MRD measurement directly...
November 13, 2020 08:00 ET | Source: Adaptive Biotechnologies

Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections

– Findings support upcoming launch of T-Detect™ COVID, first T-cell test for novel coronavirus– Data support mounting evidence that measuring T-cells is necessary to fully characterize immune...
November 10, 2020 16:13 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio

SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
November 10, 2020 16:10 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results

SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
October 13, 2020 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020

SEATTLE, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
September 01, 2020 16:03 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Conference

SEATTLE, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
August 10, 2020 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results

SEATTLE, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
August 10, 2020 08:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit

SEATTLE, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

keyboard_arrow_left Previous Page